Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This systematic review examined the reliability and validity of the Morisky Medication Adherence Scale-8 (MMAS-8), which has been widely used to assess patient medication adherence in clinical research and medical practice. METHODS: Of 418 studies identified through searching 4 electronic databases, we finally analyzed 28 studies meeting the selection criteria of this study regarding the reliability and validity of MMAS-8 including sensitivity and specificity. Meta-analysis for Cronbach's α, intraclass correlation coefficient (ICC), sensitivity and specificity to detect a patient with nonadherence to medication were performed. The pooled estimates for Cronbach's α and ICC were calculated using the random-effects weighted T transformation. A bivariate random-effects model was used to estimate pooled sensitivity and specificity. FINDINGS: The pooled Cronbach's α estimate for type 2 diabetes group in 7 studies and osteoporosis group in 3 studies were 0.67 (95% Confidence Interval(CI), 0.65 to 0.69) and 0.77 (95% CI, 0.72 to 0.83), respectively. With regard to test-retest, the pooled ICC for type 2 diabetes group in 3 studies and osteoporosis group in 2 studies were 0.81 (95% CI, 0.75 to 0.85) and 0.80 (95% CI, 0.74 to 0.85). For a cut-off value of 6, the pooled sensitivity and specificity in 12 studies were 0.43 (95% CI, 0.33 to 0.53) and 0.73 (95% CI, 0.68 to 0.78), respectively. CONCLUSIONS: The MMAS-8 had acceptable internal consistency and reproducibility in a few diseases like type 2 diabetes. Using the cut-off value of 6, criterion validity was not enough good to validly screen a patient with nonadherence to medication. However, this study did not calculated a pooled estimate for criterion validity using the higher values than 6 as a cut-off value since most of included individual studies did not report criterion validity based on those values.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The PHQ-8, MMAS, and the AAQ2 are widely used, with adequate reliability and validity (Bond et al., 2011; Moon et al., 2017; Villarreal-Zegarra et al., 2023).”
From Work-Related Cognitive Behavioral Therapy for racially and economically diverse unemployed persons with social anxiety: A randomized clinical trial (2024) · cites this paper as Moon et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
Morisky, D. E., Ang, A., Krousel‐Wood, M., & Ward, H. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07572.x · Cited by 2,877 · cited 14×
“Validation: Weon-Young Lee, Jin Seub Hwang, Donald E. Morisky.”
BackgroundMethodInfluentialSelf-citationRetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317 · cited 1×
“developed a self-reported scale with 4 items regarding common medicationtaking behaviours leading to omission of drug [12].”
BackgroundSelf-citationKirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369 · cited 1×
“Parameter estimates of this model are the summary receiver operating characteristics (SROC) curve, the summary operating point (summary values for sensitivity and specificity), a 95% confidence region around the summary operating point and a 95% prediction region based the cut-off 6 of common threshold [33].”
MethodOn the use, the misuse, and the very limited usefulness of Cronbach’s alpha
Sijtsma, K. (2009) · Psychometrika · doi:10.1007/s11336-008-9101-0 · Cited by 2,814
Cited by
Items 301–329 of 329
Chen, P.-W., Lin, M.-C., Fang, T., & Lee, M. (2026) · Biomedicines · doi:10.3390/biomedicines14030725
“Standardized instruments such as the eight-item Morisky Medication Adherence Scale (MMAS-8) have been widely validated and applied across chronic diseases [19–22], offering a practical and structured approach to assessing real-world adherence.”
Han, K., Kim, H. S., LEE, Y. K., & Lee, C.-W. (2026) · PLoS ONE · doi:10.1371/journal.pone.0345509
“Although this cutoff has practical value and allows for comparability within the Korean national survey framework, it has not been formally validated against established adherence measures such as the Morisky Medication Adherence Scale or prescription refill data [38].”
Optimisation de la prise en charge pharmaceutique des patients atteints de myélome multiple
Cransac, A. (2020) · theses.fr (ABES) · doi:10.70675/62cd02f2ze35cz46b1zbbe3z90d0d85512b4
Détection et analyse de la non-adhérence médicamenteuse dans les réseaux sociaux
Bigeard, É. (2019) · theses.fr (ABES) · doi:10.70675/3e3e0d35z4653z434dz954ezaa6c39926762 · Cited by 3
Olatunji, O. O., Patnaik, P. K., SATHIYA, V., OTU-ANSAH, J. B., & MEDE, B. N. (2026) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2026.21.1.42
Treatment response and determinants of asthma control in Eastern Africa
Getahun, K. A., Tessema, N. B., Muttamba, W., Mugenyi, L., Chakaya, J. M., Bekele, A., Abay, S. M., Baye, T. M., Yimer, G., & Kirenga, B. (2026) · BMC Pulmonary Medicine · doi:10.1186/s12890-026-04317-9
“Moreover, none of the study sites fully achieved the recommended adherence threshold of 75–80%, which corresponds to medium‑ to high‑adher‑ ence MMAS [31, 45, 46].”
Al-Sadir, H., Al-Farhood, A., Yousef, A., Abduljabbar, R., Abdullah, S., Abuhaliema, A., & Kasabri, V. N. (2026) · Pharmaceuticals · doi:10.3390/ph19050712
“Non-adherence was defined as MMAS-8 8(low adherence and medium adherence), and such patients were excluded, in line with prior validation studies [48].”
Dimitrijević, I., & Vuletić, G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26629-4.00309-9
Assisted Devices and Daily Life Adaptations in Diabetes
Das, U., Roy, D., Singh, S., & Mandal, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-8946-3_13
Etu, E. S., Fransen, J., Geda, B., Kuti, K. A., Fikrie, A., & Spigt, M. (2026) · Tropical Medicine & International Health · doi:10.1111/tmi.70164 · Cited by 1
Zimmern, P. E., Souders, C., Prokesch, B. C., Lutz, K., & Nisco, N. J. D. (2026) · medRxiv · doi:10.64898/2026.05.11.26352945
Khoiry, Q. A., Alfian, S. D., van Boven, J. F. M., Jatnika, R., & Abdulah, R. (2026) · Patient Preference and Adherence · doi:10.2147/ppa.s602433
Efectividad de la escala MMAS-8 en pacientes oncológicos mayores: un estudio piloto
amador, A. N. J. (2026) · El Repositorio Academico Digital de la UANL (Universidad Autónoma de Nuevo León)
Abebe, T. B., Alemayehu, T. T., Demelash, T. M., Asefa, H. Y., Yferu, Z. A., Sebsebe, L. W., Tilahun, R. D., Mengestu, W. N., Fikru, M. G., Gurmu, N. T., et al. (2026) · Global Health Research and Policy · doi:10.1016/j.ghrp.2026.06.007
“22,23 Associated factors were variables reported to have a statistically significant association (p-value 0.05) with medication non-adherence in multivariate analysis within the included studies.”
InfluentialAbbas, N. M., Saeed, D., & Rashid, B. Z. (2026) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v11i1.2960
“A condition characterized by an impaired ability of the heart to pump enough blood into the systemic circulation, with several risk factors identified, including smoking, hypertension, alcohol consumption, and a suspected previous history of heart disease [3].”
Jurin, I., Hadžibegović, I., Pavlov, M., Marović, M., Čikara, T., & Lucijanić, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145465
“Adherence to SGLT2i was scored using the 8-item Morisky Medication Adherence Scale (MMAS-8) [25] and categorized as high (score 8), moderate (6–7), low ( 6), or not taking.”
Ebid, A. I. M., El-Shewy, R., Mostafa, M. I., Eid, R., Mobarez, M. A., & Shash, E. (2026) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-026-04133-4
“…concordance with objective measures: (1) the traditional approach, where only patients with poor adherence (MMAS-8 score 6) were classified as non-adherent [21 ], or (2) the modified approach, where patients with poor or medium adherence (MMAS-8 score < 8) were classified as non-adherent [ 22].”
Individual and family self-management for high-risk gastrointestinal bleeding in older adults
Zhang, J.-M., Li, Y.-N., Sheng, X.-M., Shan, J., & Cui, X.-H. (2026) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.122147
Aurella, T. C., Wiyono, J., Bahari, K., & Tyas, M. D. C. (2026) · Borneo Nursing Journal (BNJ) · doi:10.61878/bnj.v8i2.1141
“…TTD. Alat pengumpulan data menggunakan kuesioner demografi, kuesioner pengetahuan tertutup (20 butir soal benar/salah diadopsi dari Nurhalimah dengan α = 0,859, dan kuesioner kepatuhan Morisky Medication Adherence Scale (MMAS-8) yang telah diadaptasi (8 butir soal skala Guttman α= 0,88 ) [6], [7].”
Shen, Q., Zeng, X., & Yu, L. (2026) · Medical Science Monitor · doi:10.12659/msm.954346
“…is a self-report measure and may underestimate non-adherence because of recall and social-desirability bias; systematic review evidence supports its usefulness as a screening tool, but it is not equivalent to objective dispensing, pill count, electronic monitoring, or biochemical measures [31].”
Ismarova, G. S., Кинванлун, И. Г., Tsoi, L., Shakhnabieva, S. M., Бекбаевна, К. Р., & Сабирович, С. И. (2026) · Heart Vessels and Transplantation · doi:10.24969/hvt.2026.689
Lu, Q., Qin, H., Zhou, S., Li, S., Chen, J., Chen, Q., & Tang, X. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0014741
“Medication adherence was quantified using the validated Chinese Morisky-8 Medication Adherence Scale (C-MMAS-8) [10].”
Khalooei, A., Hasani, M., Salehi, S., Sharifi, F., & Nakhaeizadeh, M. (2026) · Epidemiology and Health System Journal · doi:10.34172/ehsj.26625
Skrabal, X. (2020) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Nogueiras‐Álvarez, R., Roncato, R., Benić, M. S., Kapo, S. M., Potočnjak, I., & Belančić, A. (2026) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2026.2754563
Methods and strategies for detecting and preventing nonadherence in resistant hypertension
Greer, J., Kolli, D., & Dudenbostel, T. (2026) · Exploration of Medicine · doi:10.37349/emed.2026.1001433
Aminuddin, A., Collein, I., & Ismunandar, I. (2026) · JURNAL ILMIAH KESEHATAN SANDI HUSADA · doi:10.35816/jiksh.v15i2.405
Functional health literacy and medication adherence in atrial fibrillation patients
Janjani, P., Haraj, A., Nosrati, P., Hasani, V., Ardalan, P., Hasani, S., Moradinia, S., Khodaie, M. M., Dorost, M., Dehpahlevan, S., et al. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.101011
Metadata
- Authors
- Moon, S. J., Lee, W.-Y., Hwang, J. S., Hong, Y. P., & Morisky, D. E.
- Affiliations
- Chung-Ang University (KR)
- University of California, Los Angeles (US)
- Corresponding author
- Lee, Weon-Young
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-11-02
- Volume
- 12
- Issue
- 11
- Pages
- e0187139
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5667769
- OpenAlex
- W2765324371
- Cited by
- 293
- References
- 43
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 33 · 2023: 30 · 2022: 23 · 2021: 37 · 2020: 46 · 2019: 35 · 2018: 16 · 2017: 1
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-04-17)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Sociology and Political Science › Survey Methodology and Nonresponse
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- MMAS-8, medication adherence, adherence screening, psychometric properties, internal consistency, test-retest reliability, sensitivity and specificity, type 2 diabetes, osteoporosis, questionnaire validity
- MeSH terms
- Drug Therapy, Humans, Patient Compliance, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.